| 101 |
Pretreatment levels of serum osteoprotegerin and p53 protein
and urine telomerase as prognostic factors affecting survival in Egyptian bladder cancer patients |
2016 |
| 102 |
Pretreatment levels of serum osteoprotegerin and p53 protein
and urine telomerase as prognostic factors affecting survival in Egyptian bladder cancer patients |
2016 |
| 103 |
Supraclavicular Nodal Failure after
Surgery in N1 Breast Cancer Patients
without Supraclavicular Irradiation |
2016 |
| 104 |
Vulvar Cancer Surgical Treatment Complications Management; 5 Years Experience, SECI |
2016 |
| 105 |
Vulvar Cancer Surgical Treatment Complications Management; 5 Years Experience, SECI |
2016 |
| 106 |
Vulvar Cancer Surgical Treatment Complications Management; 5 Years Experience, SECI |
2016 |
| 107 |
Vulvar Cancer Surgical Treatment Complications Management; 5 Years Experience, SECI |
2016 |
| 108 |
Prognostic Value of KRAS Mutations in Codons 12 and 13 in South Egyptian Colorectal Cancer Patients |
2015 |
| 109 |
Amyloid Goiter: Clinicopathological Assessment of Two Cases and Review of Literature |
2015 |
| 110 |
Chemoradiation Compared to Surgery Alone in Patients With Non-Metastatic Esophageal Carcinoma |
2015 |
